The aim of this study was to analyze the flow cytometric S-phase fraction (
SPF) in rectal tumors before and after preoperative radiotherapy (15x2 Gy)
and to compare the findings to the clinical outcome. Archival specimens fro
m 84 cases, treated from 1980 to 1988 with S-phase data and complete follow
-up were reviewed. There was no significant correlation between SPF and cli
nicopathological factors. The median SPF for the 26 diploid tumors before i
rradiation was 6.6%+/-3.1, compared to a significantly higher median for th
e 58 preirradiated aneuploid tumors (20.3%+/-6.1; p<0.0001). With a median
follow-up of 6 years, there was a significant difference in the number of r
ecurrences for aneuploid tumors with a pretreatment SPF < and >20.3 (51.7%
vs. 20.7%; p=0.029), which also led to a significant difference in recurren
ce-free survival (p=0.05). For diploid tumors, a reduction in the percentag
e of cells in S-phase after radiation resulted in a borderline significant
lower number of recurrences (p=0.06). It is concluded that pretreatment S-p
hase measurements may be of predictive value especially for aneuploid tumor
s. An alteration in SPF after radiotherapy may also be helpful in predictin
g outcome and planning therapy.